Discounted Cash Flow
Molecular Partners AG ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $20.4m | $-36.3m | $-2.2m | -177.9% | $-1.69 |
| 2020 | $9.3m (-54.2%) | $-62.8m (-73.1%) | $-30.4m (-1270.9%) | -671.8% (-277.5%) | $-2.51 (-48.5%) |
| 2021 | $9.8m (4.4%) | $-63.8m (-1.6%) | $-91.9m (-201.9%) | -653.9% (2.7%) | $-2.06 (17.9%) |
| 2022 | $189.6m (1843.8%) | $117.9m (284.8%) | $117.9m (228.3%) | 62.2% (109.5%) | $3.63 (276.2%) |
| 2023 | $7.0m (-96.3%) | $-62.0m (-152.6%) | $-59.0m (-150.0%) | -880.7% (-1516.9%) | $-1.89 (-152.1%) |
| 2024 | $5.0m (-29.4%) | $-54.0m (12.8%) | $-59.2m (-0.4%) | -1087.3% (-23.5%) | $-1.59 (15.9%) |
| 2025 | $0 (-100.0%) | $-61.6m (-14.1%) | $-52.0m (12.3%) | — | $-1.65 (-3.8%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.